Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new document revision v3.5.4 has been added to replace the previous v3.5.3 on the study page, indicating an updated version of the study protocol or related documents.
    Difference
    0.1%
    Check dated 2026-05-15T05:43:56.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a newer ClinicalTrials.gov release revision (v3.5.3) instead of the prior version (v3.5.2).
    Difference
    0.1%
    Check dated 2026-04-24T05:47:14.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:55.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:39.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3, reflecting a new page version.
    Difference
    0.1%
    Check dated 2026-03-11T23:52:55.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1; no user-facing changes are evident.
    Difference
    0.1%
    Check dated 2026-02-11T14:12:33.000Z thumbnail image

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.